Cannabix Technologies Ramps Up Beta Testing With THC Breathalyzer and Ships Additional Devices
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it is ramping up subject beta testing in a high-volume clinic in the Northwestern US and will ship an additional THC Breath Analyzer (THCBA) unit to the site.
AGTC: The New Leader in Ocular Gene Therapy With Sue Washer
Sue Washer, president and CEO of Applied Genetic Technologies Corporation (AGTC), discusses ocular gene therapy with the Eye Care Insider podcast host Joshua Mali, MD.
Local Tech Startup Continues Breakthrough Success in Global Display Industry
UF startup and UF Innovate | The Hub resident Mattrix Technologies has found a way to use technology invented at UF to reduce OLED manufacturing costs for large screens and bring these incredible displays to a wider market.
Revisiting the A-Si Backplane for the Next Generation of AMOLED Displays
Mattrix Technologies has a new approach to AMOLED manufacturing that may soon drive costs down and adoption rates higher in many markets.
Space Startups Launch YEESS To Make Their Case in Europe Presided by SATLANTIS CEO
Six European space startups founded the Young European Enterprises Syndicate (YEESS) presided by SATLANTIS CEO Juan Tomas Hernani.
DNAtrix Announces the Appointment of David Liebowitz, M.D., Ph.D., as Chief Medical Officer
UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced the appointment of David Liebowitz, M.D., Ph.D., an industry veteran with over 20 years of experience in oncology drug and viral vaccine development, as chief medical officer.
AGTC Is Excited To Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber As Their New Chief Financial Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, announced Jonathan I. Lieber as their new Chief Financial Officer.
TearClear Files Investigational New Drug (IND) Application To Begin Its Clinical Trial for TC-002 Latanoprost Ophthalmic Solution, 0.005%
UF startup and UF Innovate | Sid Martin Biotech company TearClear, a late clinical-stage ophthalmic pharmaceutical company, has filed an Investigational New Drug (IND) application to conduct a registrational study for its lead glaucoma candidate, TC-002 latanoprost ophthalmic solution, 0.005%.
AGROVIEW Company Joins NVIDIA Inception
UF startup and UF Innovate | The Hub resident Agriculture Intelligence, the parent company of Agroview, announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in AI and data sciences.
Axogen RECON(SM) Clinical Study Completes Subject Follow-Up
UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that the RECON Clinical Study supporting its Biologics License Application (BLA) for Avance Nerve Graft has completed follow-up of study subjects.
